This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Waters resumed with an In Line at Evercore ISI
Evercore ISI resumed coverage of Waters (WAT) with an In Line rating and $360 price target. Shares have dipped by 13% post the Becton Dickinson (BDX) Life Sci transaction due to mixed results and cautious guidance, says the analyst, who notes that debate centers around management’s confidence in deal merits versus short-term concerns.
Valentine's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WAT:
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
